Cell Surgical Network Study for Stromal Vascular Fraction Registered by ClinicalTrials.gov

Rancho Mirage, CA (PRWEB) October 14, 2013 Clinicaltrials.gov, a service of the U.S. National Institutes of Health has registered on their public site an IRB approved safety study from the Cell Surgical Network, Inc.. This study is available for patients with various degenerative and inflammatory conditions to undergo Stromal Vascular Fraction deployment for the evaluation and for the…

Is a regenerative approach viable for the treatment of COPD?

Br J Pharmacol. 2011 May;163(1):106-15. doi: 10.1111/j.1476-5381.2011.01246.x. Treatment of COPD Is a regenerative approach viable for the treatment of COPD? Hind M, Maden M. Source Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK. m.hind@imperial.ac.uk Abstract Degenerative lung diseases such as chronic obstructive pulmonary disease (COPD) are common with huge worldwide morbidity.…

Stem cells and chronic lung disease

Annu Rev Med. 2007;58:285-98. Stem cells and chronic lung disease. Gomperts BN, Strieter RM. Source Mattel Children’s Hospital, Department of Pediatrics, Division of Pediatric Hematology, Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. bgomperts@mednet.ucla.edu Abstract Stem cells have been shown to contribute to the repair and regeneration of injured lungs.…

Stem cell therapy: the great promise in lung disease.

Ther Adv Respir Dis. 2008 Jun;2(3):173-7. Stem cell therapy: the great promise in lung disease. Siniscalco D, Sullo N, Maione S, Rossi F, D’Agostino B. Source Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, via S. Maria di Costantinopoli, 16-80138 Napoli, Italy. dariosin@uab.edu Abstract Lung injuries are leading causes of morbidity and…

Mesenchymal stem cells and inflammatory lung diseases.

Panminerva Med. 2009 Mar;51(1):5-16. Mesenchymal stem cells and inflammatory lung diseases. Iyer SS, Co C, Rojas M. Source Division of Pulmonary, Allergy and Critical Care Medicine, Emory University, Atlanta, GA 30322, USA. Abstract Mesenchymal stem cells (MSCs) are emerging as a therapeutic modality in various inflammatory disease states. A number of ongoing randomized Phase I/II…

Cell based therapy for COPD

[Article in Japanese] Kubo H. Source Department of Geriatrics and Gerontology, Tohoku University Hospital. Abstract To develop a new cell based therapy for chronic obstructive pulmonary disease (COPD), we need to understand 1) the role of tissue-specific and bone marrow-derived stem cells, 2) extracellular matrix, and 3) growth factors. Recently, bronchioalveolar stem cells were identified…

Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.

Expert Opin Biol Ther. 2010 May;10(5):681-7. Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. D’Agostino B, Sullo N, Siniscalco D, De Angelis A, Rossi F. Source Department of Experimental Medicine, Second University of Naples, Section of Pharmacology L Donatelli, via S Maria di Costantinopoli, 16-80138 Napoli, Italy. bruno.dagostino@unina2.it Abstract Recent studies…